EUVIMEDEUVIMED entdecken
Multizentrische Studie

Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life

David Balayssac, Nicolas Kerckhove, Marie Selvy, Bruno Pereira, Coralie Gonneau, Caroline Pétorin, Agnès Vimal-Baguet, Sergey Melnikov, Sharif Kullab, Mohamed Hebbar, Olivier Bouché, Florian Slimano und 15 weitere

Supportive Care in Cancer · 2024-07 · 32 (7)

DOI: 10.1007/s00520-024-08627-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 13.06.2024. Verfasst von David Balayssac und 26 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1107 NEURO-DOL, CHU Clermont-Ferrand, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France. dbalayssac@chu-clermontferrand.fr. Hauptthemen laut MEDLINE: Oxaliplatin, Quality of Life, Peripheral Nervous System Diseases, Colorectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Sensory chemotherapy-induced peripheral neuropathy (CIPN) is well-recognized, but motor CIPN remains understudied. This secondary analysis focused on the long-term severity and impact of motor disorders, their relation to sensory CIPN, neuropathic pain, psychological distress, and health-related quality of life (HRQoL) after oxaliplatin-based chemotherapy in colorectal cancer (CRC) survivors. METHODS: Data from a multicenter, cross-sectional study were re-analyzed to explore motor CIPN among CRC survivors up to 5 years post-chemotherapy, with no longitudinal follow-up. Questionnaires assessed sensory and motor CIPN (QLQ-CIPN20), neuropathic pain (DN4), anxiety and depression (HADS), and HRQoL (QLQ-C30). RESULTS: Among 405 CRC survivors, 31.1% had sensory CIPN as previously described. When categorizing the 405 CRC survivors based on the years since their last oxaliplatin-based chemotherapy, the motor scores derived from the QLQ-CIPN20 showed no significant difference between years (p = 0.08). Motor CIPN scores correlated with female gender, higher oxaliplatin dose intensity, sensory CIPN, and neuropathic pain. Motor CIPN also linked to decreased HRQoL and increased psychological distress. CONCLUSION: The study underscores the detrimental impact of motor disorders on CRC survivors post-oxaliplatin-based chemotherapy. Oncologists should prioritize assessing and managing motor manifestations alongside sensory symptoms to enhance post-cancer quality of life. TRIAL REGISTRATION: NCT02970526 (2016-11-22). https://classic. CLINICALTRIALS: gov/ct2/show/NCT02970526?term=NCT02970526&draw=2&rank=1 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxaliplatinQuality of LifePeripheral Nervous System DiseasesColorectal NeoplasmsAntineoplastic AgentsHumansMaleFemaleMiddle AgedCross-Sectional StudiesAgedSurveys and QuestionnairesSeverity of Illness IndexMotor DisordersNeuralgiaAdultCancer Survivors

Stichwörter der Autor:innen

Cancer survivorsChemotherapy-induced peripheral neuropathyColorectal cancerMotor disordersOxaliplatin

Substanzen

OxaliplatinAntineoplastic Agents

Autor:innen und Institutionen

  • INSERM U1107 NEURO-DOL, CHU Clermont-Ferrand, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France. dbalayssac@chu-clermontferrand.fr.
  • INSERM U1107 NEURO-DOL, CHU Clermont-Ferrand, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France.
  • Direction à la Recherche Clinique et de l'Innovation, CHU Clermont-Ferrand, F-63000, Clermont-Ferrand, France.
  • INSERM U1107 NEURO-DOL, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France.
  • Service Oncologie digestive, CHU Clermont-Ferrand, F-63000, Clermont-Ferrand, France.
  • Service Chirurgie générale et viscérale, Centre Hospitalier de Saint-Flour, F-15100, Saint-Flour, France.

Zitieren

APA

Balayssac, D., Kerckhove, N., Selvy, M., Pereira, B., Gonneau, C., Pétorin, C., Vimal-Baguet, A., Melnikov, S., Kullab, S., Hebbar, M., Bouché, O., Slimano, F., Bourgeois, V., Lebrun-Ly, V., Thuillier, F., Mazard, T., Tavan, D., Benmammar, K. E., Monange, B., …, & Martin, V. (2024). Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life. Supportive Care in Cancer, 32(7). https://doi.org/10.1007/s00520-024-08627-8

Vancouver

Balayssac D, Kerckhove N, Selvy M, Pereira B, Gonneau C, Pétorin C, et al. Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life. Supportive Care in Cancer. 2024;32(7). doi:10.1007/s00520-024-08627-8

BibTeX
@article{Balayssac2024,
  author = {Balayssac, David and Kerckhove, Nicolas and Selvy, Marie and Pereira, Bruno and Gonneau, Coralie and Pétorin, Caroline and Vimal-Baguet, Agnès and Melnikov, Sergey and Kullab, Sharif and Hebbar, Mohamed and Bouché, Olivier and Slimano, Florian and Bourgeois, Vincent and Lebrun-Ly, Valérie and Thuillier, Frédéric and Mazard, Thibault and Tavan, David and Benmammar, Kheir-Eddine and Monange, Brigitte and Ramdani, Mohamed and Péré-Vergé, Denis and Huet-Penz, Floriane and Bedjaoui, Ahmed and Genty, Florent and Leyronnas, Cécile and Pezet, Denis and Martin, Vincent},
  title = {Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life},
  journal = {Supportive Care in Cancer},
  year = {2024},
  volume = {32},
  number = {7},
  doi = {10.1007/s00520-024-08627-8}
}
Kostenlos starten →